IRIS Accounts Production v26.1.0.640 09201886 Board of Directors 31.7.25 1.8.24 31.7.25 31.7.25 Medium entities These accounts have been prepared in accordance with the provisions applicable to companies subject to the medium-sized companies regime. true true true false true true false false false false false false false false false false false false false true false Ordinary 0 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh092018862024-07-31092018862025-07-31092018862024-08-012025-07-31092018862023-07-31092018862023-08-012024-07-31092018862024-07-3109201886ns15:EnglandWales2024-08-012025-07-3109201886ns14:PoundSterling2024-08-012025-07-3109201886ns10:Director12024-08-012025-07-3109201886ns10:Consolidated2025-07-3109201886ns10:ConsolidatedGroupCompanyAccounts2024-08-012025-07-3109201886ns10:PrivateLimitedCompanyLtd2024-08-012025-07-3109201886ns10:Consolidatedns10:MediumEntities2024-08-012025-07-3109201886ns10:Consolidatedns10:Audited2024-08-012025-07-3109201886ns10:SmallCompaniesRegimeForAccounts2024-08-012025-07-3109201886ns10:Consolidated2024-08-012025-07-3109201886ns10:Consolidatedns10:Medium-sizedCompaniesRegimeForDirectorsReport2024-08-012025-07-3109201886ns10:Medium-sizedCompaniesRegimeForAccountsns10:Consolidated2024-08-012025-07-3109201886ns10:FullAccounts2024-08-012025-07-3109201886ns5:Subsidiary12024-08-012025-07-3109201886ns5:Subsidiary22024-08-012025-07-3109201886ns5:Subsidiary32024-08-012025-07-3109201886ns5:Subsidiary42024-08-012025-07-3109201886ns5:Subsidiary52024-08-012025-07-3109201886ns5:Subsidiary62024-08-012025-07-3109201886ns5:Subsidiary72024-08-012025-07-3109201886ns5:Subsidiary82024-08-012025-07-3109201886ns5:Subsidiary92024-08-012025-07-3109201886ns5:Subsidiary102024-08-012025-07-310920188612024-08-012025-07-3109201886ns10:OrdinaryShareClass12024-08-012025-07-3109201886ns10:RegisteredOffice2024-08-012025-07-3109201886ns10:Director22024-08-012025-07-3109201886ns10:Consolidated2023-08-012024-07-3109201886ns5:CurrentFinancialInstruments2025-07-3109201886ns5:CurrentFinancialInstruments2024-07-3109201886ns5:Non-currentFinancialInstruments2025-07-3109201886ns5:Non-currentFinancialInstruments2024-07-3109201886ns5:ShareCapital2025-07-3109201886ns5:ShareCapital2024-07-3109201886ns5:RetainedEarningsAccumulatedLosses2025-07-3109201886ns5:RetainedEarningsAccumulatedLosses2024-07-3109201886ns5:ShareCapital2023-07-3109201886ns5:RetainedEarningsAccumulatedLosses2023-07-3109201886ns5:RetainedEarningsAccumulatedLosses2023-08-012024-07-3109201886ns5:RetainedEarningsAccumulatedLosses2024-08-012025-07-3109201886ns5:NetGoodwill2024-08-012025-07-3109201886ns5:IntangibleAssetsOtherThanGoodwill2024-08-012025-07-3109201886ns5:OwnedOrFreeholdAssetsns5:LandBuildings2024-08-012025-07-3109201886ns5:LeaseholdImprovements2024-08-012025-07-3109201886ns5:PlantMachinery2024-08-012025-07-3109201886ns5:FurnitureFittings2024-08-012025-07-3109201886ns5:MotorVehicles2024-08-012025-07-3109201886ns5:ComputerEquipment2024-08-012025-07-3109201886ns5:LandBuildings2024-07-3109201886ns5:LeaseholdImprovements2024-07-3109201886ns5:FurnitureFittings2024-07-3109201886ns5:ComputerEquipment2024-07-3109201886ns5:LandBuildings2024-08-012025-07-3109201886ns5:LandBuildings2025-07-3109201886ns5:LeaseholdImprovements2025-07-3109201886ns5:FurnitureFittings2025-07-3109201886ns5:ComputerEquipment2025-07-3109201886ns5:LandBuildings2024-07-3109201886ns5:LeaseholdImprovements2024-07-3109201886ns5:FurnitureFittings2024-07-3109201886ns5:ComputerEquipment2024-07-3109201886ns5:CostValuation2024-07-31092018861ns5:Subsidiary12024-08-012025-07-3109201886ns5:Subsidiary232024-08-012025-07-31092018865ns5:Subsidiary32024-08-012025-07-3109201886ns5:Subsidiary472024-08-012025-07-31092018869ns5:Subsidiary52024-08-012025-07-3109201886ns5:Subsidiary6112024-08-012025-07-310920188613ns5:Subsidiary72024-08-012025-07-3109201886ns5:Subsidiary8152024-08-012025-07-310920188617ns5:Subsidiary92024-08-012025-07-310920188619ns5:Subsidiary102024-08-012025-07-3109201886ns5:WithinOneYearns5:CurrentFinancialInstruments2025-07-3109201886ns5:WithinOneYearns5:CurrentFinancialInstruments2024-07-3109201886ns5:Non-currentFinancialInstrumentsns5:BetweenOneTwoYears2025-07-3109201886ns5:Non-currentFinancialInstrumentsns5:BetweenOneTwoYears2024-07-3109201886ns5:Non-currentFinancialInstrumentsns5:BetweenTwoFiveYears2025-07-3109201886ns5:Non-currentFinancialInstrumentsns5:BetweenTwoFiveYears2024-07-3109201886ns5:Secured2025-07-3109201886ns5:Secured2024-07-3109201886ns10:OrdinaryShareClass12025-07-31
REGISTERED NUMBER: 09201886 (England and Wales)









GROUP STRATEGIC REPORT, REPORT OF THE DIRECTORS AND

CONSOLIDATED FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 JULY 2025

FOR

GENIECARE HOMES LIMITED

GENIECARE HOMES LIMITED (REGISTERED NUMBER: 09201886)






CONTENTS OF THE CONSOLIDATED FINANCIAL STATEMENTS
for the Year Ended 31 July 2025





Page


Company Information 1

Group Strategic Report 2

Report of the Directors 4

Report of the Independent Auditors 6

Consolidated Profit and Loss Account 10

Consolidated Other Comprehensive Income 11

Consolidated Balance Sheet 12

Company Balance Sheet 13

Consolidated Statement of Changes in Equity 14

Company Statement of Changes in Equity 15

Consolidated Cash Flow Statement 16

Notes to the Consolidated Cash Flow Statement 17

Notes to the Consolidated Financial Statements 19


GENIECARE HOMES LIMITED

COMPANY INFORMATION
for the Year Ended 31 July 2025







DIRECTORS: Mrs S B Butt





REGISTERED OFFICE: River Cottage
Horton Road
Horton
Bristol
BS37 6QH





REGISTERED NUMBER: 09201886 (England and Wales)





AUDITORS: Kingscott Dix (Cheltenham) Limited
Statutory Auditor
Chartered Accountants
7 Rockfield Business Park
Old Station Drive
Leckhampton
Cheltenham
GL53 0AN

GENIECARE HOMES LIMITED (REGISTERED NUMBER: 09201886)

GROUP STRATEGIC REPORT
for the Year Ended 31 July 2025

The directors present their strategic report of the company and the group for the year ended 31 July 2025.

REVIEW OF BUSINESS
The Group has continued to perform strongly during the year, with turnover increasing to £25.6m (2024 - £22.1m). This growth reflects continued high levels of occupancy across the care home portfolio, careful cost control, and sustained demand for quality residential care services where the Group operates.

The Group achieved an operating profit of £5.4m (2024 - £4.7m) and profit before taxation of £4.3m (2024 - £3.7m). Cash generation from operations remained robust, enabling the Group to continue investing in its property portfolio, whilst also meeting its financing and tax obligations as they fell due.

During the year, the Group continued to invest in the maintenance and improvement of its care homes, with capital expenditure of approximately £3.7m, ensuring that facilities remain compliant with regulatory standards and continue to meet the needs of residents.

The directors consider the Group’s financial position at the year end to be satisfactory, with net assets of £14.8m (2024 - £12.9m) and adequate liquidity to support ongoing operations and planned investment.

PRINCIPAL RISKS AND UNCERTAINTIES
The directors have identified the principal risks and uncertainties facing the Group and have taken steps to manage and mitigate these risks where possible.

Regulatory compliance
The Group operates in a highly regulated sector and is subject to oversight by relevant care and health regulators. Failure to comply with regulatory requirements could result in enforcement action or reputational damage. The Group mitigates this risk through robust governance, staff training, regular internal reviews, and engagement with regulators.

Staffing
The recruitment and retention of suitably qualified care staff remains a key risk given industry-wide labour shortages and cost pressures. The Group seeks to mitigate this risk through competitive remuneration, investment in training, and maintaining a positive working environment.

Financial funding
The Group has significant bank borrowings used to finance acquisitions and development. There is a risk associated with interest rate movements and compliance with banking covenants. This risk is managed through regular cash flow forecasting, close liaison with lenders, and maintaining appropriate headroom within facilities.

Occupancy
The Group’s financial performance is dependent on maintaining high occupancy levels. Changes in local demand, competition, or reputational issues could impact occupancy. The Group mitigates this risk through maintaining high standards of care, ongoing investment in facilities, and strong local relationships.

Cost inflation
The Group is exposed to increases in costs, particularly staffing, utilities, and food costs. Management actively monitors margins, reviews pricing structures where appropriate, and seeks efficiencies without compromising care quality.


GENIECARE HOMES LIMITED (REGISTERED NUMBER: 09201886)

GROUP STRATEGIC REPORT
for the Year Ended 31 July 2025

KEY PERFORMANCE INDICATORS
The directors monitor the performance of the Group using a range of financial and non-financial key performance indicators, including:

Turnover growth - reflecting occupancy levels and fee rates.

Operating profit and margins - measuring operational efficiency.

Cash generated from operations - ensuring adequate liquidity.

Occupancy rates across care homes - monitoring utilisation of capacity.

Regulatory inspection outcomes - maintaining quality and compliance standards.

FUTURE DEVELOPMENTS
The directors remain optimistic about the Group’s prospects. Demand for quality residential care continues to be strong, driven by demographic trends. The Group will continue to focus on maintaining high standards of care, investing in its facilities and workforce, and managing costs prudently.

ON BEHALF OF THE BOARD:





Mrs S B Butt - Director


15 April 2026

GENIECARE HOMES LIMITED (REGISTERED NUMBER: 09201886)

REPORT OF THE DIRECTORS
for the Year Ended 31 July 2025

The directors present their report with the financial statements of the company and the group for the year ended 31 July 2025.

PRINCIPAL ACTIVITY
The principal activity of the group in the year under review was that of operating care homes.

DIVIDENDS
The total distribution of dividends for the year ended 31 July 2025 will be £1,036,113 for the group. This is comprised
of £169,038 from the parent company and £867,075 from the subsidiary companies.

DIRECTORS
Mrs S B Butt has held office during the whole of the period from 1 August 2024 to the date of this report.

Other changes in directors holding office are as follows:

Mr R G Butt - deceased 31 July 2025

STATEMENT OF DIRECTORS' RESPONSIBILITIES
The directors are responsible for preparing the Group Strategic Report, the Report of the Directors and the financial statements in accordance with applicable law and regulations.

Company law requires the directors to prepare financial statements for each financial year. Under that law the directors have elected to prepare the financial statements in accordance with United Kingdom Generally Accepted Accounting Practice (United Kingdom Accounting Standards and applicable law). Under company law the directors must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the company and the group and of the profit or loss of the group for that period. In preparing these financial statements, the directors are required to:

- select suitable accounting policies and then apply them consistently;
- make judgements and accounting estimates that are reasonable and prudent;
- prepare the financial statements on the going concern basis unless it is inappropriate to presume that the company will continue in business.

The directors are responsible for keeping adequate accounting records that are sufficient to show and explain the company's and the group's transactions and disclose with reasonable accuracy at any time the financial position of the company and the group and enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the company and the group and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.


STATEMENT AS TO DISCLOSURE OF INFORMATION TO AUDITORS
So far as the directors are aware, there is no relevant audit information (as defined by Section 418 of the Companies Act 2006) of which the group's auditors are unaware, and each director has taken all the steps that she ought to have taken as a director in order to make herself aware of any relevant audit information and to establish that the group's auditors are aware of that information.

GENIECARE HOMES LIMITED (REGISTERED NUMBER: 09201886)

REPORT OF THE DIRECTORS
for the Year Ended 31 July 2025


AUDITORS
The auditors, Kingscott Dix (Cheltenham) Limited, will be proposed for re-appointment at the forthcoming Annual General Meeting.

ON BEHALF OF THE BOARD:





Mrs S B Butt - Director


15 April 2026

REPORT OF THE INDEPENDENT AUDITORS TO THE MEMBERS OF
GENIECARE HOMES LIMITED

Opinion
We have audited the financial statements of Geniecare Homes Limited (the 'parent company') and its subsidiaries (the 'group') for the year ended 31 July 2025 which comprise the Consolidated Profit and Loss Account, Consolidated Other Comprehensive Income, Consolidated Balance Sheet, Company Balance Sheet, Consolidated Statement of Changes in Equity, Company Statement of Changes in Equity, Consolidated Cash Flow Statement and Notes to the Consolidated Cash Flow Statement, Notes to the Financial Statements, including a summary of significant accounting policies. The financial reporting framework that has been applied in their preparation is applicable law and United Kingdom Accounting Standards, including Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland' (United Kingdom Generally Accepted Accounting Practice).

In our opinion the financial statements:
-give a true and fair view of the state of the group's and of the parent company affairs as at 31 July 2025 and of the group's profit for the year then ended;
-have been properly prepared in accordance with United Kingdom Generally Accepted Accounting Practice; and
-have been prepared in accordance with the requirements of the Companies Act 2006.

Basis for opinion
We conducted our audit in accordance with International Standards on Auditing (UK) (ISAs (UK)) and applicable law. Our responsibilities under those standards are further described in the Auditors' responsibilities for the audit of the financial statements section of our report. We are independent of the group in accordance with the ethical requirements that are relevant to our audit of the financial statements in the UK, including the FRC's Ethical Standard, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.

Conclusions relating to going concern
In auditing the financial statements, we have concluded that the directors' use of the going concern basis of accounting in the preparation of the financial statements is appropriate.

Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the group's and the parent company's ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue.

Our responsibilities and the responsibilities of the directors with respect to going concern are described in the relevant sections of this report.

Other information
The directors are responsible for the other information. The other information comprises the information in the Group Strategic Report and the Report of the Directors, but does not include the financial statements and our Report of the Auditors thereon.

Our opinion on the financial statements does not cover the other information and, except to the extent otherwise explicitly stated in our report, we do not express any form of assurance conclusion thereon.

In connection with our audit of the financial statements, our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the financial statements or our knowledge obtained in the audit or otherwise appears to be materially misstated. If we identify such material inconsistencies or apparent material misstatements, we are required to determine whether this gives rise to a material misstatement in the financial statements themselves. If, based on the work we have performed, we conclude that there is a material misstatement of this other information, we are required to report that fact. We have nothing to report in this regard.

Opinions on other matters prescribed by the Companies Act 2006
In our opinion, based on the work undertaken in the course of the audit:
- the information given in the Group Strategic Report and the Report of the Directors for the financial year for which the financial statements are prepared is consistent with the financial statements; and
- the Group Strategic Report and the Report of the Directors have been prepared in accordance with applicable legal requirements.

REPORT OF THE INDEPENDENT AUDITORS TO THE MEMBERS OF
GENIECARE HOMES LIMITED


Matters on which we are required to report by exception
In the light of the knowledge and understanding of the group and the parent company and its environment obtained in the course of the audit, we have not identified material misstatements in the Group Strategic Report or the Report of the Directors.

We have nothing to report in respect of the following matters where the Companies Act 2006 requires us to report to you if, in our opinion:
- adequate accounting records have not been kept by the parent company, or returns adequate for our audit have not been received from branches not visited by us; or
- the parent company financial statements are not in agreement with the accounting records and returns; or
- certain disclosures of directors' remuneration specified by law are not made; or
- we have not received all the information and explanations we require for our audit.

Responsibilities of directors
As explained more fully in the Statement of Directors' Responsibilities set out on page four, the directors are responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view, and for such internal control as the directors determine necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error.

In preparing the financial statements, the directors are responsible for assessing the group's and the parent company's ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the directors either intend to liquidate the group or the parent company or to cease operations, or have no realistic alternative but to do so.

REPORT OF THE INDEPENDENT AUDITORS TO THE MEMBERS OF
GENIECARE HOMES LIMITED


Auditors' responsibilities for the audit of the financial statements
Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue a Report of the Auditors that includes our opinion. Reasonable assurance is a high level of assurance, but is not a guarantee that an audit conducted in accordance with ISAs (UK) will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements.

The extent to which our procedures are capable of detecting irregularities, including fraud is detailed below:

We identified areas of law and regulations that could reasonably be expected to have a material effect on the financial statements from: our commercial and sector experience; our accountancy and tax knowledge; inspection of the Group's relevant correspondence; a review of Companies House filings; and discussions with the Directors. We discussed laws and regulations throughout our team and remained alert to any indication of non-compliance throughout the audit. The potential effect of the law and regulations on the financial statements varies considerably.

Firstly, the Group is subject to laws and regulations that directly affect the financial statements including financial
reporting legislation, distributable profits legislation and taxation legislation. We assessed the extent of compliance with these laws and regulations as part of our procedures on the related financial statement items.

Secondly, the Group is subject to other laws and regulations where the consequences of non-compliance could have a material effect on amounts disclosed in the financial statements, for instance through the imposition of fines or litigation. We identified the following areas as those most likely to have such an effect: food safety, health and safety, medical care, and employment laws and regulations, recognising the nature of the Group's activities. Auditing standards limit the required audit procedures to identify non-compliance with these laws and regulations to enquiries of management, and inspection of regulatory and legal correspondence, if any. These limited procedures did not identify actual or suspected non-compliance.

Due to the inherent limitations of an audit, there is an unavoidable risk that we may not have detected some material
misstatements in the financial statements, even though we have properly planned and performed our audit in accordance with auditing standards. As with any audit, there remained a higher risk of non-detection of irregularities, as these may involve collusion, forgery, intentional omissions, misrepresentations, or the override of internal controls. We are not responsible for preventing non-compliance and cannot be expected to detect non-compliance with all laws and regulations.

A further description of our responsibilities for the audit of the financial statements is located on the Financial Reporting Council's website at www.frc.org.uk/auditorsresponsibilities. This description forms part of our Report of the Auditors.

REPORT OF THE INDEPENDENT AUDITORS TO THE MEMBERS OF
GENIECARE HOMES LIMITED


Use of our report
This report is made solely to the company's members, as a body, in accordance with Chapter 3 of Part 16 of the Companies Act 2006. Our audit work has been undertaken so that we might state to the company's members those matters we are required to state to them in a Report of the Auditors and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the company and the company's members as a body, for our audit work, for this report, or for the opinions we have formed.




Robert Harris FCA (Senior Statutory Auditor)
for and on behalf of Kingscott Dix (Cheltenham) Limited
Statutory Auditor
Chartered Accountants
7 Rockfield Business Park
Old Station Drive
Leckhampton
Cheltenham
GL53 0AN

15 April 2026

GENIECARE HOMES LIMITED (REGISTERED NUMBER: 09201886)

CONSOLIDATED
PROFIT AND LOSS ACCOUNT
for the Year Ended 31 July 2025

2025 2024
Notes £    £   

TURNOVER 3 25,580,274 22,050,735

Cost of sales (15,467,887 ) (12,939,918 )
GROSS PROFIT 10,112,387 9,110,817

Administrative expenses (4,685,390 ) (4,387,852 )
5,426,997 4,722,965

Other operating income 40 334
OPERATING PROFIT 5 5,427,037 4,723,299

Interest receivable and similar income 89,182 27,118
5,516,219 4,750,417

Interest payable and similar expenses 6 (1,202,962 ) (1,017,381 )
PROFIT BEFORE TAXATION 4,313,257 3,733,036

Tax on profit 7 (1,385,813 ) (1,095,755 )
PROFIT FOR THE FINANCIAL YEAR 2,927,444 2,637,281
Profit attributable to:
Owners of the parent 2,927,444 2,637,281

GENIECARE HOMES LIMITED (REGISTERED NUMBER: 09201886)

CONSOLIDATED
OTHER COMPREHENSIVE INCOME
for the Year Ended 31 July 2025

2025 2024
Notes £    £   

PROFIT FOR THE YEAR 2,927,444 2,637,281


OTHER COMPREHENSIVE INCOME
Attributable to minority interests (472,117 ) (403,828 )
Income tax relating to other comprehensive
income

-

-
OTHER COMPREHENSIVE INCOME
FOR THE YEAR, NET OF INCOME TAX

(472,117

)

(403,828

)
TOTAL COMPREHENSIVE INCOME
FOR THE YEAR

2,455,327

2,233,453

Total comprehensive income attributable to:
Owners of the parent 1,983,210 1,829,625
Non-controlling interests 472,117 403,828
2,455,327 2,233,453

GENIECARE HOMES LIMITED (REGISTERED NUMBER: 09201886)

CONSOLIDATED BALANCE SHEET
31 July 2025

2025 2024
Notes £    £   
FIXED ASSETS
Intangible assets 10 302,284 344,384
Tangible assets 11 24,755,492 22,057,743
Investments 12 - -
25,057,776 22,402,127

CURRENT ASSETS
Debtors 13 1,218,754 1,537,648
Cash at bank and in hand 8,624,829 7,688,681
9,843,583 9,226,329
CREDITORS
Amounts falling due within one year 14 (3,331,819 ) (3,576,282 )
NET CURRENT ASSETS 6,511,764 5,650,047
TOTAL ASSETS LESS CURRENT
LIABILITIES

31,569,540

28,052,174

CREDITORS
Amounts falling due after more than one year 15 (16,487,081 ) (15,011,683 )

PROVISIONS FOR LIABILITIES 19 (251,742 ) (101,105 )
NET ASSETS 14,830,717 12,939,386

CAPITAL AND RESERVES
Called up share capital 20 100 100
Retained earnings 21 12,050,272 10,631,058
SHAREHOLDERS' FUNDS 12,050,372 10,631,158

NON-CONTROLLING INTERESTS 22 2,780,345 2,308,228
TOTAL EQUITY 14,830,717 12,939,386

The financial statements were approved by the Board of Directors and authorised for issue on 15 April 2026 and were signed on its behalf by:





Mrs S B Butt - Director


GENIECARE HOMES LIMITED (REGISTERED NUMBER: 09201886)

COMPANY BALANCE SHEET
31 July 2025

2025 2024
Notes £    £   
FIXED ASSETS
Intangible assets 10 - -
Tangible assets 11 3,551,333 3,670,580
Investments 12 1,527,483 1,527,483
5,078,816 5,198,063

CURRENT ASSETS
Debtors 13 2,797,087 3,962,589
Cash at bank and in hand 3,254 5,413
2,800,341 3,968,002
CREDITORS
Amounts falling due within one year 14 (1,245,421 ) (1,921,644 )
NET CURRENT ASSETS 1,554,920 2,046,358
TOTAL ASSETS LESS CURRENT
LIABILITIES

6,633,736

7,244,421

CREDITORS
Amounts falling due after more than one year 15 (4,216,073 ) (4,468,669 )
NET ASSETS 2,417,663 2,775,752

CAPITAL AND RESERVES
Called up share capital 20 100 100
Retained earnings 2,417,563 2,775,652
SHAREHOLDERS' FUNDS 2,417,663 2,775,752

Company's loss for the financial year (189,051 ) (139,301 )

The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements were approved by the Board of Directors and authorised for issue on 15 April 2026 and were signed on its behalf by:





Mrs S B Butt - Director


GENIECARE HOMES LIMITED (REGISTERED NUMBER: 09201886)

CONSOLIDATED STATEMENT OF CHANGES IN EQUITY
for the Year Ended 31 July 2025

Called up
share Retained Non-controlling Total
capital earnings Total interests equity
£    £    £    £    £   
Balance at 1 August 2023 100 8,822,293 8,822,393 1,904,400 10,726,793

Changes in equity
Dividends - (424,688 ) (424,688 ) - (424,688 )
Total comprehensive income - 2,233,453 2,233,453 403,828 2,637,281
Balance at 31 July 2024 100 10,631,058 10,631,158 2,308,228 12,939,386

Changes in equity
Dividends - (1,036,113 ) (1,036,113 ) - (1,036,113 )
Total comprehensive income - 2,455,327 2,455,327 472,117 2,927,444
Balance at 31 July 2025 100 12,050,272 12,050,372 2,780,345 14,830,717

GENIECARE HOMES LIMITED (REGISTERED NUMBER: 09201886)

COMPANY STATEMENT OF CHANGES IN EQUITY
for the Year Ended 31 July 2025

Called up
share Retained Total
capital earnings equity
£    £    £   
Balance at 1 August 2023 100 3,055,379 3,055,479

Changes in equity
Dividends - (140,426 ) (140,426 )
Total comprehensive income - (139,301 ) (139,301 )
Balance at 31 July 2024 100 2,775,652 2,775,752

Changes in equity
Dividends - (169,038 ) (169,038 )
Total comprehensive income - (189,051 ) (189,051 )
Balance at 31 July 2025 100 2,417,563 2,417,663

GENIECARE HOMES LIMITED (REGISTERED NUMBER: 09201886)

CONSOLIDATED CASH FLOW STATEMENT
for the Year Ended 31 July 2025

2025 2024
Notes £    £   
Cash flows from operating activities
Cash generated from operations 1 7,241,531 6,478,416
Interest paid (1,185,462 ) (1,011,219 )
Interest element of hire purchase payments
paid

(17,500

)

(6,162

)
Tax paid (1,775,521 ) (1,065,911 )
Net cash from operating activities 4,263,048 4,395,124

Cash flows from investing activities
Purchase of tangible fixed assets (3,673,962 ) (5,005,860 )
Sale of tangible fixed assets 27,850 51,311
Interest received 89,182 27,118
Net cash from investing activities (3,556,930 ) (4,927,431 )

Cash flows from financing activities
New bank loans in year 2,200,000 3,800,000
Bank loan repayments in year (873,508 ) (711,968 )
Hire purchase repayments in year (60,349 ) (2,245 )
Equity dividends paid (1,036,113 ) (424,688 )
Net cash from financing activities 230,030 2,661,099

Increase in cash and cash equivalents 936,148 2,128,792
Cash and cash equivalents at beginning of
year

2

7,688,681

5,559,889

Cash and cash equivalents at end of year 2 8,624,829 7,688,681

GENIECARE HOMES LIMITED (REGISTERED NUMBER: 09201886)

NOTES TO THE CONSOLIDATED CASH FLOW STATEMENT
for the Year Ended 31 July 2025

1. RECONCILIATION OF PROFIT BEFORE TAXATION TO CASH GENERATED FROM OPERATIONS

2025 2024
£    £   
Profit before taxation 4,313,257 3,733,036
Depreciation charges 1,177,921 1,027,829
Loss on disposal of fixed assets 1,755 -
Finance costs 1,202,962 1,017,381
Finance income (89,182 ) (27,118 )
6,606,713 5,751,128
Decrease in trade and other debtors 318,794 231,833
Increase in trade and other creditors 316,024 495,455
Cash generated from operations 7,241,531 6,478,416

2. CASH AND CASH EQUIVALENTS

The amounts disclosed on the Cash Flow Statement in respect of cash and cash equivalents are in respect of these Balance Sheet amounts:

Year ended 31 July 2025
31.7.25 1.8.24
£    £   
Cash and cash equivalents 8,624,829 7,688,681
Year ended 31 July 2024
31.7.24 1.8.23
£    £   
Cash and cash equivalents 7,688,681 5,559,889


GENIECARE HOMES LIMITED (REGISTERED NUMBER: 09201886)

NOTES TO THE CONSOLIDATED CASH FLOW STATEMENT
for the Year Ended 31 July 2025

3. ANALYSIS OF CHANGES IN NET DEBT

Other
non-cash
At 1.8.24 Cash flow changes At 31.7.25
£    £    £    £   
Net cash
Cash at bank
and in hand 7,688,681 936,148 8,624,829
7,688,681 936,148 8,624,829
Debt
Finance leases (209,402 ) (341,081 ) - (361,270 )
Debts falling due
within 1 year (661,387 ) 45,304 - (616,083 )
Debts falling due
after 1 year (14,854,478 ) (1,348,792 ) - (16,203,270 )
(15,725,267 ) (1,644,569 ) - (17,180,623 )
Total (8,036,586 ) (708,421 ) - (8,555,794 )

GENIECARE HOMES LIMITED (REGISTERED NUMBER: 09201886)

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
for the Year Ended 31 July 2025

1. STATUTORY INFORMATION

Geniecare Homes Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the General Information page.

The presentation currency of the financial statements is the Pound Sterling (£).


2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Basis of consolidation
The consolidated group accounts of Geniecare Homes Limited are derived from the financial statements of the company and its subsidiaries and other related companies over which it can exercise control, all prepared in accordance with group accounting policies with reference to FRS 102.

The assets, liabilities, costs and revenues of the individual consolidated companies are fully consolidated on a line-by-line basis, regardless of the percentage owned, while the carrying value of consolidated investments held by Geniecare Homes Limited is eliminated against the related share of equity.

All intercompany balances and transactions, including unrealised profits deriving from transactions between
consolidated companies, are eliminated.

Geniecare Homes Ltd has given a parental guarantee pursuant to section 479A of the Companies Act 2006, for its subsidiary companies. The subsidiary companies are therefore exempt from the requirement to have an audit of their financial statements.

Significant judgements and estimates
No significant judgements or estimations have been used in preparing the financial statements.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Goodwill
Goodwill, being the amount paid in connection with the acquisition of a business in 2015, is being amortised evenly over its estimated useful life of ten years.

Intangible assets
Intangible assets are initially measured at cost. After initial recognition, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.

GENIECARE HOMES LIMITED (REGISTERED NUMBER: 09201886)

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS - continued
for the Year Ended 31 July 2025

2. ACCOUNTING POLICIES - continued

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Freehold property - Straight line over 50 years
Improvements to property - 10% on cost, Straight line over 20 years and Straight line over 10 years
Plant and machinery - 25% on reducing balance, 20% on reducing balance and 15% on reducing balance
Fixtures and fittings - 20% on reducing balance, 20% on cost and 15% on reducing balance
Motor vehicles - 25% on reducing balance and 25% on cost
Computer equipment - 33% on cost and 15% on cost

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Consolidated Profit and Loss Account, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Hire purchase and leasing commitments
Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease.

Pension costs and other post-retirement benefits
The group operates a defined contribution pension scheme. Contributions payable to the group's pension scheme are charged to profit or loss in the period to which they relate.

Financial instruments
The company only has financial assets and financial liabilities of a kind that qualify as basic financial
instruments. Basic financial instruments are initially recognised at transaction value and subsequently measured at their settlement value.

GENIECARE HOMES LIMITED (REGISTERED NUMBER: 09201886)

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS - continued
for the Year Ended 31 July 2025

3. TURNOVER

The turnover and profit before taxation are attributable to the one principal activity of the group.

An analysis of turnover by class of business is given below:

2025 2024
£    £   
Provision of residential care 24,630,471 21,452,587
Provision of home care 949,803 598,148
25,580,274 22,050,735

4. EMPLOYEES AND DIRECTORS
2025 2024
£    £   
Wages and salaries 13,893,399 12,393,982
Social security costs 1,003,078 626,899
Other pension costs 207,901 169,852
15,104,378 13,190,733

The average number of employees during the year was as follows:
2025 2024

Provision of residential care 436 434
Provision of home care 27 26
Directors and key management 5 5
468 465

The directors of the parent company and subsidiary companies are considered key management personnel.

2025 2024
£    £   
Directors' remuneration 494,256 594,258

Information regarding the highest paid director is as follows:
2025 2024
£    £   
Emoluments etc 245,183 486,357

GENIECARE HOMES LIMITED (REGISTERED NUMBER: 09201886)

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS - continued
for the Year Ended 31 July 2025

5. OPERATING PROFIT

The operating profit is stated after charging:

2025 2024
£    £   
Hire of plant and machinery 8,994 10,548
Other operating leases 66,102 61,028
Depreciation - owned assets 1,135,821 832,990
Loss on disposal of fixed assets 1,755 -
Goodwill amortisation 42,100 194,838
Auditors remuneration 11,000 -

6. INTEREST PAYABLE AND SIMILAR EXPENSES
2025 2024
£    £   
Bank loan interest 1,185,462 1,011,219
Hire purchase 17,500 6,162
1,202,962 1,017,381

7. TAXATION

Analysis of the tax charge
The tax charge on the profit for the year was as follows:
2025 2024
£    £   
Current tax:
UK corporation tax 1,235,177 1,065,911

Deferred tax 150,636 29,844
Tax on profit 1,385,813 1,095,755

GENIECARE HOMES LIMITED (REGISTERED NUMBER: 09201886)

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS - continued
for the Year Ended 31 July 2025

7. TAXATION - continued

Reconciliation of total tax charge included in profit and loss
The tax assessed for the year is higher than the standard rate of corporation tax in the UK. The difference is explained below:

2025 2024
£    £   
Profit before tax 4,313,257 3,733,036
Profit multiplied by the standard rate of corporation tax in the UK of 25 %
(2024 - 25 %)

1,078,314

933,259

Effects of:
Expenses not deductible for tax purposes 27 38,311
Depreciation in excess of capital allowances 235,345 144,517
Tax losses carried forward 72,127 334
Other items - (20,666 )
Total tax charge 1,385,813 1,095,755

Tax effects relating to effects of other comprehensive income

2025
Gross Tax Net
£    £    £   
Attributable to minority interests (472,117 ) - (472,117 )

2024
Gross Tax Net
£    £    £   
Attributable to minority interests (403,828 ) - (403,828 )

8. INDIVIDUAL PROFIT AND LOSS ACCOUNT

As permitted by Section 408 of the Companies Act 2006, the Profit and loss account of the parent company is not presented as part of these financial statements.


9. DIVIDENDS
2025 2024
£    £   
Ordinary shares of £1 each
Interim 1,036,113 424,688

During the year, dividends of £1,036,113 were paid to directors of the parent and subsidiary companies (2024 - £424,688).

GENIECARE HOMES LIMITED (REGISTERED NUMBER: 09201886)

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS - continued
for the Year Ended 31 July 2025

10. INTANGIBLE FIXED ASSETS

Group
Goodwill
£   
COST
At 1 August 2024
and 31 July 2025 2,672,005
AMORTISATION
At 1 August 2024 2,327,621
Amortisation for year 42,100
At 31 July 2025 2,369,721
NET BOOK VALUE
At 31 July 2025 302,284
At 31 July 2024 344,384

11. TANGIBLE FIXED ASSETS

Group
Improvements
Freehold to Plant and
property property machinery
£    £    £   
COST
At 1 August 2024 20,604,742 3,616,662 105,604
Additions 2,476,201 554,899 20,947
Disposals - - -
At 31 July 2025 23,080,943 4,171,561 126,551
DEPRECIATION
At 1 August 2024 1,768,598 1,309,304 68,484
Charge for year 435,619 336,094 12,932
Eliminated on disposal - - -
At 31 July 2025 2,204,217 1,645,398 81,416
NET BOOK VALUE
At 31 July 2025 20,876,726 2,526,163 45,135
At 31 July 2024 18,836,144 2,307,358 37,120

GENIECARE HOMES LIMITED (REGISTERED NUMBER: 09201886)

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS - continued
for the Year Ended 31 July 2025

11. TANGIBLE FIXED ASSETS - continued

Group

Fixtures
and Motor Computer
fittings vehicles equipment Totals
£    £    £    £   
COST
At 1 August 2024 1,721,323 393,687 81,172 26,523,190
Additions 560,655 241,687 8,786 3,863,175
Disposals - (44,980 ) - (44,980 )
At 31 July 2025 2,281,978 590,394 89,958 30,341,385
DEPRECIATION
At 1 August 2024 1,095,845 169,957 53,259 4,465,447
Charge for year 213,966 125,512 11,698 1,135,821
Eliminated on disposal - (15,375 ) - (15,375 )
At 31 July 2025 1,309,811 280,094 64,957 5,585,893
NET BOOK VALUE
At 31 July 2025 972,167 310,300 25,001 24,755,492
At 31 July 2024 625,478 223,730 27,913 22,057,743

At the balance sheet date, the group held assets acquired under hire purchase contracts with a cost of £502,606 (2024 - £266,380) and accumulated depreciation of £202,510 (2024 - £86,778).

Company
Improvements Fixtures
Freehold to and Computer
property property fittings equipment Totals
£    £    £    £    £   
COST
At 1 August 2024
and 31 July 2025 3,939,851 293,736 173,109 4,541 4,411,237
DEPRECIATION
At 1 August 2024 480,759 133,931 124,131 1,836 740,657
Charge for year 78,797 29,301 9,796 1,353 119,247
At 31 July 2025 559,556 163,232 133,927 3,189 859,904
NET BOOK VALUE
At 31 July 2025 3,380,295 130,504 39,182 1,352 3,551,333
At 31 July 2024 3,459,092 159,805 48,978 2,705 3,670,580

GENIECARE HOMES LIMITED (REGISTERED NUMBER: 09201886)

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS - continued
for the Year Ended 31 July 2025

12. FIXED ASSET INVESTMENTS

Company
Shares in
group
undertaking
£   
COST
At 1 August 2024
and 31 July 2025 1,527,483
NET BOOK VALUE
At 31 July 2025 1,527,483
At 31 July 2024 1,527,483

The group or the company's investments at the Balance Sheet date in the share capital of companies include the following:

Subsidiaries

Craigdale Care Ltd
Registered office: River Cottage, Horton Road, Horton, Bristol, BS37 6QH
Nature of business: Operates care homes
%
Class of shares: holding
Ordinary 100.00

The Worthies Residential Care Homes Ltd
Registered office: River Cottage, Horton Road, Horton, Bristol, BS37 6QH
Nature of business: Operates care homes
%
Class of shares: holding
Ordinary 100.00

The Elm (Stapleton) Ltd
Registered office: River Cottage, Horton Road, Horton, Bristol, BS37 6QH
Nature of business: Operates care homes
%
Class of shares: holding
Ordinary 100.00

The Firs Care Home (Calne) Ltd
Registered office: River Cottage, Horton Road, Horton, Bristol, BS37 6QH
Nature of business: Operates care homes
%
Class of shares: holding
Ordinary 100.00

GENIECARE HOMES LIMITED (REGISTERED NUMBER: 09201886)

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS - continued
for the Year Ended 31 July 2025

12. FIXED ASSET INVESTMENTS - continued

The Granville Care Home Ltd
Registered office: River Cottage, Horton Road, Horton, Bristol, BS37 6QH
Nature of business: Operates care homes
%
Class of shares: holding
Ordinary 50.00

Westgreen Care Ltd
Registered office: River Cottage, Horton Road, Horton, Bristol, BS37 6QH
Nature of business: Operates care homes
%
Class of shares: holding
Ordinary 50.00

Juniper Court Care Ltd
Registered office: River Cottage, Horton Road, Horton, Bristol, BS37 6QH
Nature of business: Operates care homes
%
Class of shares: holding
Ordinary 70.00

Westin Care Ltd
Registered office: River Cottage, Horton Road, Horton, Bristol, BS37 6QH
Nature of business: Operates care homes
%
Class of shares: holding
Ordinary 100.00

Kestrel Care Village Ltd
Registered office: River Cottage, Horton Road, Horton, Bristol, BS37 6QH
Nature of business: Operates care homes
%
Class of shares: holding
Ordinary 100.00

The Firs Home Care Ltd
Registered office: River Cottage, Horton Road, Horton, Bristol, BS37 6QH
Nature of business: Home care agency
%
Class of shares: holding
Ordinary 60.00


GENIECARE HOMES LIMITED (REGISTERED NUMBER: 09201886)

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS - continued
for the Year Ended 31 July 2025

13. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

Group Company
2025 2024 2025 2024
£    £    £    £   
Trade debtors 800,645 956,578 - -
Amounts owed by group undertakings - - 2,789,517 3,955,070
Other debtors 418,109 581,070 7,570 7,519
1,218,754 1,537,648 2,797,087 3,962,589

14. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

Group Company
2025 2024 2025 2024
£    £    £    £   
Bank loans and overdrafts (see note 16) 616,083 661,387 - -
Hire purchase contracts (see note 17) 77,459 52,197 - -
Trade creditors 438,152 292,186 7,139 8,077
Amounts owed to group undertakings - - 1,151,143 1,832,016
Social security and other taxes 1,147,740 1,577,842 58,879 55,931
Other creditors 1,052,385 992,670 28,260 25,620
3,331,819 3,576,282 1,245,421 1,921,644

15. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE
YEAR

Group Company
2025 2024 2025 2024
£    £    £    £   
Bank loans (see note 16) 16,203,270 14,854,478 4,216,073 4,468,669
Hire purchase contracts (see note 17) 283,811 157,205 - -
16,487,081 15,011,683 4,216,073 4,468,669

GENIECARE HOMES LIMITED (REGISTERED NUMBER: 09201886)

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS - continued
for the Year Ended 31 July 2025

16. LOANS

An analysis of the maturity of loans is given below:

Group Company
2025 2024 2025 2024
£    £    £    £   
Amounts falling due within one year or on demand:
Bank loans 616,083 661,387 - -
Amounts falling due between one and two years:
Bank loans - 1-2 years 2,369,150 484,043 252,596 467,931
Amounts falling due between two and five years:
Bank loans - 2-5 years 6,073,028 9,328,211 1,177,673 1,044,293
Amounts falling due in more than five years:
Repayable by instalments
Bank loans more 5 yr by instal 7,761,092 5,042,224 2,785,804 2,956,445

17. LEASING AGREEMENTS

Minimum lease payments fall due as follows:

Group
Hire purchase
contracts
2025 2024
£    £   
Net obligations repayable:
Within one year 77,459 52,197
Between one and five years 283,811 157,205
361,270 209,402

GENIECARE HOMES LIMITED (REGISTERED NUMBER: 09201886)

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS - continued
for the Year Ended 31 July 2025

18. SECURED DEBTS

The following secured debts are included within creditors:

Group Company
2025 2024 2025 2024
£    £    £    £   
Bank loans 16,819,353 - 4,216,073 4,468,669
Hire purchase contracts 361,270 - - -
17,180,623 - 4,216,073 4,468,669

Bank loans are secured by charges over the group, with intercompany guarantees in place between group companies.

Assets acquired under hire purchase contracts are secured on the assets to which they relate.

19. PROVISIONS FOR LIABILITIES

Group
2025 2024
£    £   
Deferred tax 251,742 101,105

Group
Deferred
tax
£   
Balance at 1 August 2024 101,105
Charge to Profit and Loss Account during year 150,637
Balance at 31 July 2025 251,742

Deferred tax relates to accelerated capital allowances. The provision is due to unwind as the group continues to depreciate its assets.

20. CALLED UP SHARE CAPITAL

Allotted and issued:
Number: Class: Nominal 2025 2024
value: £    £   
100 Ordinary shares £1 100 100

GENIECARE HOMES LIMITED (REGISTERED NUMBER: 09201886)

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS - continued
for the Year Ended 31 July 2025

21. RESERVES

Group
Retained
earnings
£   

At 1 August 2024 10,631,058
Profit for the year 2,927,444
Dividends (1,036,113 )
Minority interest profits (750,465 )
Minority interest dividends 278,348
At 31 July 2025 12,050,272

Retained earnings represent accumulated profits and losses, less dividends paid.

22. NON-CONTROLLING INTERESTS

Four subsidiary companies within the group have minority shareholders. The group recognises separately the profits and losses attributable to these non-controlling interests.

For the year ended 31 July 2025, profit after tax of £750,465 (2024 - £551,090) was attributable to such minority interests. In addition, dividends of £278,348 (2024 - £147,262) were paid to minority interests.

At 31 July 2025, the proportion of retained profits attributable to minority interests was £2,780,345.

23. RELATED PARTY DISCLOSURES

The company has taken advantage of exemption, under the terms of FRS 102, not to disclose related party transactions between fellow group companies.

Transactions between group entities which have been eliminated on consolidation are not disclosed within the financial statements.

24. ULTIMATE CONTROLLING PARTY

The ultimate controlling party is Mrs S B Butt.